Regarding the CSCs from chondrosarcomas and soft tissue sarcomas, chondrosarcoma CSC, Ch-P4, react to treatments with AA and DHA with an abrupt decrease in viability between 5 and 10 mM regardless of the absence/presence of bFGF in the culturing medium. The gene discussed is FGF2; the disease is chondrosarcoma.